Curcumin Pyrazole and its derivative (N-(3-Nitrophenylpyrazole) Curcumin inhibit aggregation, disrupt fibrils and modulate toxicity of Wild type and Mutant α-Synuclein
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Curcumin Pyrazole and its derivative (N-(3-Nitrophenylpyrazole) Curcumin inhibit
aggregation, disrupt fibrils and modulate toxicity of Wild type and Mutant
α-Synuclein
Authors
Keywords
-
Journal
Scientific Reports
Volume 5, Issue 1, Pages -
Publisher
Springer Nature
Online
2015-05-18
DOI
10.1038/srep09862
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Structures of the E46K Mutant-Type α-Synuclein Protein and Impact of E46K Mutation on the Structures of the Wild-Type α-Synuclein Protein
- (2013) Olivia Wise-Scira et al. ACS Chemical Neuroscience
- Stable and Potent Analogues Derived from the Modification of the Dicarbonyl Moiety of Curcumin
- (2013) Soumyananda Chakraborti et al. BIOCHEMISTRY
- Inhibiting toxic aggregation of amyloidogenic proteins: A therapeutic strategy for protein misfolding diseases
- (2013) Biao Cheng et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- α-Synuclein: The Long Distance Runner
- (2013) Sonia George et al. BRAIN PATHOLOGY
- Curcumin Modulates α-Synuclein Aggregation and Toxicity
- (2012) Pradeep K. Singh et al. ACS Chemical Neuroscience
- Fibrillar α-Synuclein and Huntingtin Exon 1 Assemblies Are Toxic to the Cells
- (2012) Laura Pieri et al. BIOPHYSICAL JOURNAL
- Direct Observation of the Interconversion of Normal and Toxic Forms of α-Synuclein
- (2012) Nunilo Cremades et al. CELL
- Curcumin Prevents Aggregation in α-Synuclein by Increasing Reconfiguration Rate
- (2012) Basir Ahmad et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Alpha-synuclein: from secretion to dysfunction and death
- (2012) O Marques et al. Cell Death & Disease
- Aβ(1-42) Aggregates into Non-Toxic Amyloid Assemblies in the Presence of the Natural Polyphenol Oleuropein Aglycon
- (2011) Stefania Rigacci et al. Current Alzheimer Research
- Inhibition and disaggregation of α-synuclein oligomers by natural polyphenolic compounds
- (2011) Mario Caruana et al. FEBS LETTERS
- Curcumin Recognizes a Unique Binding Site of Tubulin
- (2011) Soumyananda Chakraborti et al. JOURNAL OF MEDICINAL CHEMISTRY
- Newly Synthesized Curcumin Derivatives: Crosstalk between Chemico-physical Properties and Biological Activity
- (2011) Erika Ferrari et al. JOURNAL OF MEDICINAL CHEMISTRY
- Misfolded protein aggregates: Mechanisms, structures and potential for disease transmission
- (2011) Ines Moreno-Gonzalez et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Isoxazole analogs of curcuminoids with highly potent multidrug-resistant antimycobacterial activity
- (2010) Chatchawan Changtam et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Synthesis and Identification of New 4-Arylidene Curcumin Analogues as Potential Anticancer Agents Targeting Nuclear Factor-κB Signaling Pathway
- (2010) Xu Qiu et al. JOURNAL OF MEDICINAL CHEMISTRY
- Distinct Region-Specific -Synuclein Oligomers in A53T Transgenic Mice: Implications for Neurodegeneration
- (2010) E. Tsika et al. JOURNAL OF NEUROSCIENCE
- Biophysics of Parkinsons Disease: Structure and Aggregation of α- Synuclein
- (2009) Vladimir Uversky et al. CURRENT PROTEIN & PEPTIDE SCIENCE
- The thioflavin T fluorescence assay for amyloid fibril detection can be biased by the presence of exogenous compounds
- (2009) Sean A. Hudson et al. FEBS Journal
- Multiple system atrophy: an update
- (2009) Nadia Stefanova et al. LANCET NEUROLOGY
- Synthesis and exploration of novel curcumin analogues as anti-malarial agents
- (2008) Satyendra Mishra et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Curcumin-Derived Pyrazoles and Isoxazoles: Swiss Army Knives or Blunt Tools for Alzheimer's Disease?
- (2007) Rajeshwar Narlawar et al. ChemMedChem
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started